COCP READ THE FULL COCP RESEARCH REPORT Business Update Norovirus Challenge Study to Commence in 4Q25 Cocrystal Pharma, Inc. ...

“The absence of any approved norovirus treatments or vaccines creates a substantial market opportunity for Cocrystal,” said James Martin, Cocrystal's CFO and co-CEO. “ With 685 million global cases ...

Preparations are underway for a Phase 1b norovirus challenge study to evaluate our potent, oral antiviral candidate CDI-988 as a prophylaxis and ...

All CDI-988 doses, ranging from 100 mg to 1200 mg, in the Phase 1 study were well toleratedCompany expects to initiate Phase 1b study with CDI-988 in norovirus-infected healthy subjects later this ...

Hengrui Pharma will lead the development of these programmes up to completion of phase I trials, including patients outside of China. GSK will have the exclusive option to further develop and ...

German biotechnology company Coriolis Pharma has chosen Morrisville for its first U.S. facility and headquarters, becoming the inaugural tenant of the Spark Axis Building. The company plans a $10 ...

Whether Kennedy hands down a ban or one is passed on Capitol Hill, pharma marketing is set to undergo a significant transformation.

Torrent Pharma to Acquire Controlling Stake in J. B. Chemicals & Pharmaceuticals from KKRAcquisition to be followed by merger; strengthens Torrent’s IPM market presence ...

India's Torrent Pharmaceuticals said on Sunday it will acquire a 46.39% controlling stake in smaller peer JB Chemicals and Pharmaceuticals from New York-based investment firm KKR , and plans to ...

Fifty-five attorneys general around the country have now signed on to a $7.4 billion settlement with drugmaker Purdue Pharma and its owners, the Sackler family, over the opioid crisis, officials said.

The attorneys general of all 50 states, Washington D.C., and four territories have agreed to sign on to a $7.4 billion settlement with Purdue Pharma and the members of the Sackler family who own th… ...